510 related articles for article (PubMed ID: 25378424)
21. Randomized Assessment of the Safety and Efficacy of Intra-Arterial Infusion of Autologous Stem Cells in Subacute Ischemic Stroke.
Bhatia V; Gupta V; Khurana D; Sharma RR; Khandelwal N
AJNR Am J Neuroradiol; 2018 May; 39(5):899-904. PubMed ID: 29545253
[TBL] [Abstract][Full Text] [Related]
22. Intrathecal Injection of Allogenic Bone Marrow-Derived Mesenchymal Stromal Cells in Treatment of Patients with Severe Ischemic Stroke: Study Protocol for a Randomized Controlled Observer-Blinded Trial.
Deng L; Peng Q; Wang H; Pan J; Zhou Y; Pan K; Li J; Wu Y; Wang Y
Transl Stroke Res; 2019 Apr; 10(2):170-177. PubMed ID: 29796934
[TBL] [Abstract][Full Text] [Related]
23. Thrombectomy in patients ineligible for iv tPA (THRILL).
Bendszus M; Thomalla G; Knauth M; Hacke W; Bonekamp S; Fiehler J
Int J Stroke; 2015 Aug; 10(6):950-5. PubMed ID: 26044962
[TBL] [Abstract][Full Text] [Related]
24. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
25. Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.
van Besien K; Margolin K; Champlin R; Forman S
Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S54-8. PubMed ID: 9457395
[TBL] [Abstract][Full Text] [Related]
26. Intracoronary infusion of autologous mononuclear bone marrow cells in patients with acute myocardial infarction treated with primary PCI: Pilot study of the multicenter HEBE trial.
Hirsch A; Nijveldt R; van der Vleuten PA; Tio RA; van der Giessen WJ; Marques KM; Doevendans PA; Waltenberger J; Ten Berg JM; Aengevaeren WR; Biemond BJ; Tijssen JG; van Rossum AC; Piek JJ; Zijlstra F
Catheter Cardiovasc Interv; 2008 Feb; 71(3):273-81. PubMed ID: 18288734
[TBL] [Abstract][Full Text] [Related]
27. Phase I/II Study of Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Chronic Stroke.
Levy ML; Crawford JR; Dib N; Verkh L; Tankovich N; Cramer SC
Stroke; 2019 Oct; 50(10):2835-2841. PubMed ID: 31495331
[TBL] [Abstract][Full Text] [Related]
28. Intra-Arterial Injection of Autologous Bone Marrow-Derived Mononuclear Cells in Ischemic Stroke Patients.
Hammadi AMA; Alhimyari F
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):239-241. PubMed ID: 30777565
[TBL] [Abstract][Full Text] [Related]
29. Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice.
Wei N; Yu SP; Gu X; Taylor TM; Song D; Liu XF; Wei L
Cell Transplant; 2013; 22(6):977-91. PubMed ID: 23031629
[TBL] [Abstract][Full Text] [Related]
30. Chinese medicine neuroaid efficacy on stroke recovery: a double-blind, placebo-controlled, randomized study.
Chen CL; Young SH; Gan HH; Singh R; Lao AY; Baroque AC; Chang HM; Hiyadan JH; Chua CL; Advincula JM; Muengtaweepongsa S; Chan BP; de Silva HA; Towanabut S; Suwanwela NC; Poungvarin N; Chankrachang S; Wong KS; Eow GB; Navarro JC; Venketasubramanian N; Lee CF; Bousser MG;
Stroke; 2013 Aug; 44(8):2093-100. PubMed ID: 23780952
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness and Safety of Autologous Bone Marrow Stromal Cells Transplantation After Ischemic Stroke: A Meta-Analysis.
Cao W; Li P
Med Sci Monit; 2015 Jul; 21():2190-5. PubMed ID: 26215395
[TBL] [Abstract][Full Text] [Related]
32. Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial.
Díez-Tejedor E; Gutiérrez-Fernández M; Martínez-Sánchez P; Rodríguez-Frutos B; Ruiz-Ares G; Lara ML; Gimeno BF
J Stroke Cerebrovasc Dis; 2014; 23(10):2694-2700. PubMed ID: 25304723
[TBL] [Abstract][Full Text] [Related]
33. Stem cell therapy: a clinical trial of stroke.
Bhasin A; Srivastava MV; Mohanty S; Bhatia R; Kumaran SS; Bose S
Clin Neurol Neurosurg; 2013 Jul; 115(7):1003-8. PubMed ID: 23183251
[TBL] [Abstract][Full Text] [Related]
34. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial.
Hirsch A; Nijveldt R; van der Vleuten PA; Tijssen JG; van der Giessen WJ; Tio RA; Waltenberger J; ten Berg JM; Doevendans PA; Aengevaeren WR; Zwaginga JJ; Biemond BJ; van Rossum AC; Piek JJ; Zijlstra F;
Eur Heart J; 2011 Jul; 32(14):1736-47. PubMed ID: 21148540
[TBL] [Abstract][Full Text] [Related]
35. Relationships Between Imaging Assessments and Outcomes in Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke.
Albers GW; Goyal M; Jahan R; Bonafe A; Diener HC; Levy EI; Pereira VM; Cognard C; Yavagal DR; Saver JL
Stroke; 2015 Oct; 46(10):2786-94. PubMed ID: 26316344
[TBL] [Abstract][Full Text] [Related]
36. Transfection of Noggin in bone marrow stromal cells (BMSCs) enhances BMSC-induced functional outcome after stroke in rats.
Chen C; Cheng Y; Chen J
J Neurosci Res; 2011 Aug; 89(8):1194-202. PubMed ID: 21544853
[TBL] [Abstract][Full Text] [Related]
37. Intravenous autologous bone marrow mononuclear cells for ischemic stroke.
Savitz SI; Misra V; Kasam M; Juneja H; Cox CS; Alderman S; Aisiku I; Kar S; Gee A; Grotta JC
Ann Neurol; 2011 Jul; 70(1):59-69. PubMed ID: 21786299
[TBL] [Abstract][Full Text] [Related]
38. Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.
Hirsch A; Nijveldt R; van der Vleuten PA; Biemond BJ; Doevendans PA; van Rossum AC; Tijssen JG; Zijlstra F; Piek JJ;
Am Heart J; 2006 Sep; 152(3):434-41. PubMed ID: 16923409
[TBL] [Abstract][Full Text] [Related]
39. Treatment evaluation of acute stroke for using in regenerative cell elements (TREASURE) trial: Rationale and design.
Osanai T; Houkin K; Uchiyama S; Minematsu K; Taguchi A; Terasaka S
Int J Stroke; 2018 Jun; 13(4):444-448. PubMed ID: 29134924
[TBL] [Abstract][Full Text] [Related]
40. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II).
Adams HP; Effron MB; Torner J; Dávalos A; Frayne J; Teal P; Leclerc J; Oemar B; Padgett L; Barnathan ES; Hacke W;
Stroke; 2008 Jan; 39(1):87-99. PubMed ID: 18032739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
